Downregulated MYL1 Emerges as a Promising Diagnostic Biomarker for Rheumatoid Arthritis
MYL1 is consistently downregulated in RA and may serve as a potential diagnostic biomarker. The results indicate that MYL1 may be involved in the pathological process of RA through calcium signaling, muscle function, and immune cell regulation. However, further clinical and mechanistic studies are warranted.
Authors
- William W. Lu (ORCID: https://orcid.org/0000-0002-5780-2886)
- Yi Dan (ORCID: https://orcid.org/0000-0001-7714-2259)
- Haidong Chen (ORCID: https://orcid.org/0000-0001-6476-5748)
- Wenjun Hao (ORCID: https://orcid.org/0000-0002-9854-035X)
- Can Yang (ORCID: https://orcid.org/0000-0002-4407-3055)
- Wuxuan Qin (ORCID: https://orcid.org/0009-0003-3753-9317)
- Xifan Zheng (ORCID: https://orcid.org/0000-0002-6185-8778)
- Yan Chen (ORCID: https://orcid.org/0000-0002-5962-5713)
- Yicheng Liang (ORCID: https://orcid.org/0000-0002-1299-5709)
- Han Tang
- Zhiling Huang (ORCID: https://orcid.org/0009-0007-9673-7435)
Institutions
- Guangxi Medical University (CN)
- Chinese University of Hong Kong (HK)
- First Affiliated Hospital of GuangXi Medical University (CN)
- Shenzhen Institutes of Advanced Technology (CN)
- University of Hong Kong (HK)
Publication Details
- Journal
- Journal of Inflammation Research
- Published
- 2025-12-01
- DOI
- https://doi.org/10.2147/jir.s551219
- Primary Topic
- Rheumatoid Arthritis Research and Therapies
- Type
- article
- Field-Weighted Citation Impact
- 0.00